Robert Janknegt
Robert Janknegt publishes mostly in Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases, on topics such as Antibiotics Pharmacokinetics and Efficacy, Pharmaceutical studies and practices and Pneumonia and Respiratory Infections.
- World rank
- #5,852,587 of 7,710,434 ranked researchers
- Rank in Netherlands
- #97,301 of 107,149
- Works
- 62
- Citations
- 1k
- Citations per work
- 16.9
What does Robert Janknegt research?
Robert Janknegt's work is mostly in Medicine (35%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3658.0%
- Health Sciences2235.2%
- Medicine2235.2%
- Social Sciences46.8%
- 1Pharmacology9% of their works
- 2Pediatrics, Perinatology and Child Health9% of their works
- 3Infectious Diseases7% of their works
- 4Economics and Econometrics7% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Epidemiology6% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical studies and practices
- Pneumonia and Respiratory Infections
- Health Systems, Economic Evaluations, Quality of Life
- Cancer therapeutics and mechanisms
- Antibiotic Use and Resistance
- Atrial Fibrillation Management and Outcomes
- Diabetes Management and Research
Which keywords describe Robert Janknegt's research?
The keywords of their largest research topics: Antimicrobial Resistance, Antibiotic Pharmacokinetics, Critically Ill Patients, Epidemiology, Off-Label Drug Use, Pediatric Pharmacokinetics, Community-Acquired Pneumonia and Pneumococcal Conjugate Vaccine.
- Topoisomerases
- Diabetes
- Atrial Fibrillation
- Anticoagulant Therapy
- Quality of Life
- Pneumococcal Conjugate Vaccine
- Pediatric Pharmacokinetics
- Epidemiology
- Antibiotic Pharmacokinetics
- Antimicrobial Resistance
- Critically Ill Patients
- Off-Label Drug Use
- Community-Acquired Pneumonia
- Cost-effectiveness Analysis
- Antibiotic Resistance
- Antimicrobial Stewardship
- DNA
- Hypoglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antimicrobial Resistance182 topics
- Antibiotic Pharmacokinetics111 topic
- Critically Ill Patients111 topic
- Epidemiology112 topics
- Off-Label Drug Use101 topic
- Pediatric Pharmacokinetics101 topic
- Community-Acquired Pneumonia71 topic
- Pneumococcal Conjugate Vaccine71 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Antibiotic Resistance41 topic
- Anticoagulant Therapy41 topic
- Antimicrobial Stewardship41 topic
- Atrial Fibrillation41 topic
- DNA41 topic
- Diabetes41 topic
- Hypoglycemia41 topic
- Topoisomerases41 topic
Where does Robert Janknegt work?
Robert Janknegt's main affiliation in the publication record is Maaslandziekenhuis, Netherlands.
How many publications and citations does Robert Janknegt have?
OpenAlex counts 62 works and 1,047 citations for Robert Janknegt, an h-index of 15, ranking #5,852,587 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert Janknegt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.